Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

AUTORISEREDE FYSIOTERAPEUTER AULUM ApS

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.6%   Bankruptcy risk   2.6% 2.2% 2.0% 2.1% 1.8% 2.1% 14.7% 9.4%   Credit score (0-100)   63 68 70 67 70 67 13 26   Credit rating   BBB BBB A A A A BB BB   Credit limit (kDKK)   0.0 0.1 0.2 0.1 0.9 0.1 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,770 1,754 1,869 2,283 2,691 2,779 0.0 0.0   EBITDA   605 534 513 283 375 379 0.0 0.0   EBIT   316 407 462 223 278 170 0.0 0.0   Pre-tax profit (PTP)   317.0 416.7 475.7 239.5 290.2 160.1 0.0 0.0   Net earnings   247.6 322.6 371.0 186.6 226.1 124.7 0.0 0.0   Pre-tax profit without non-rec. items   317 417 476 239 290 160 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Tangible assets total   134 82.4 121 104 1,081 906 0.0 0.0   Shareholders equity total   501 624 694 581 657 632 407 407   Interest-bearing liabilities   0.0 0.0 0.0 0.0 430 198 0.0 0.0   Balance sheet total (assets)   853 956 1,064 1,186 1,749 1,572 407 407   Net Debt   -245 -206 -419 -381 178 -68.4 -407 -407     See the entire balance sheet 1000.0 Volume  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,770 1,754 1,869 2,283 2,691 2,779 0.0 0.0   Gross profit growth   0.2% -0.9% 6.6% 22.1% 17.9% 3.3% -100.0% 0.0%   Employees   2 2 3 4 4 4 0 0   Employee growth %   0.0% 0.0% 50.0% 33.3% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   853 956 1,064 1,186 1,749 1,572 407 407   Balance sheet change%   -38.5% 12.1% 11.3% 11.4% 47.5% -10.1% -74.1% 0.0%   Added value   316.0 407.5 462.3 223.0 278.2 170.2 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -578 -252 -11 -77 881 -384 -906 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 4.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   17.9% 23.2% 24.7% 9.8% 10.3% 6.1% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   28.6% 46.1% 47.1% 21.3% 19.8% 10.5% 0.0% 0.0%   ROI %   41.1% 73.4% 72.0% 36.5% 32.8% 16.9% 0.0% 0.0%   ROE %   51.9% 57.4% 56.3% 29.3% 36.5% 19.3% 0.0% 0.0%   1000.0 Solidity  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Equity ratio %   58.7% 65.2% 65.3% 49.0% 37.6% 40.2% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -40.6% -38.6% -81.8% -134.7% 47.6% -18.0% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% 65.4% 31.4% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   1.2% 0.0% 0.0% 0.0% 0.4% 4.7% 0.0% 0.0%   1000.0 Liquidity  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Quick Ratio   1.9 2.6 2.5 1.9 0.6 0.7 0.0 0.0   Current Ratio   1.9 2.6 2.6 1.9 0.7 0.8 0.0 0.0   Cash and cash equivalent   245.5 206.0 419.1 381.1 251.5 266.8 0.0 0.0   1000.0 Capital use efficiency  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   304.4 536.4 576.6 511.7 -351.3 -194.8 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   158 204 154 56 70 43 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   302 267 171 71 94 95 0 0   EBIT / employee   158 204 154 56 70 43 0 0   Net earnings / employee   124 161 124 47 57 31 0 0